Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis

NCT03757351 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
15
Enrollment
INDUSTRY
Sponsor class

Stopped Due to change in Sanofi's development strategy for DNL747/SAR443060 - not due to any safety concerns

Conditions

Interventions

Sponsor

Sanofi

Collaborators